Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Kilarski

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Hospital Pharmacy|November 7, 1981
Trends in cost containment: where do we cut?P J Schneider, D J Kilarski
The New England Journal of Medicine|November 1, 1984
Soft-tissue damage associated with intravenous phenytoinD J Kilarski, C Buchanan, L Von Behren
Drug Intelligence & Clinical Pharmacy|March 1, 1984
Tobramycin-furosemide interactionJ S Kaka, C Lyman, D J Kilarski
American Journal of Hospital Pharmacy|April 1, 1983
Particulate matter in four reconstituted cephalosporin injectionsD J Kilarski, J A Visconti, S G Frank
American Journal of Hospital Pharmacy|August 1, 1982
Establishing a fee for handling investigational drug studiesB Q Ngu, P J Schneider, D J Kilarski
Hospital Formulary|August 8, 1986
Adverse drug reaction reporting system: developing a well-monitored programD J Kilarski, B Ziegler, J Coarse, et al.
American Journal of Hospital Pharmacy|October 1, 1981
Use review of intravenous infusion devicesD J Kilarski, P J Schneider, S M Teil, et al.
Archives of Internal Medicine|June 1, 1988
Severe soft-tissue injury following intravenous infusion of phenytoin. Patient and drug administration risk factorsR F Spengler, J B Arrowsmith, D J Kilarski, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Hospital Pharmacy|November 7, 1981
Trends in cost containment: where do we cut?P J Schneider, D J Kilarski
The New England Journal of Medicine|November 1, 1984
Soft-tissue damage associated with intravenous phenytoinD J Kilarski, C Buchanan, L Von Behren
Drug Intelligence & Clinical Pharmacy|March 1, 1984
Tobramycin-furosemide interactionJ S Kaka, C Lyman, D J Kilarski
American Journal of Hospital Pharmacy|April 1, 1983
Particulate matter in four reconstituted cephalosporin injectionsD J Kilarski, J A Visconti, S G Frank
American Journal of Hospital Pharmacy|August 1, 1982
Establishing a fee for handling investigational drug studiesB Q Ngu, P J Schneider, D J Kilarski
Hospital Formulary|August 8, 1986
Adverse drug reaction reporting system: developing a well-monitored programD J Kilarski, B Ziegler, J Coarse, et al.
American Journal of Hospital Pharmacy|October 1, 1981
Use review of intravenous infusion devicesD J Kilarski, P J Schneider, S M Teil, et al.
Archives of Internal Medicine|June 1, 1988
Severe soft-tissue injury following intravenous infusion of phenytoin. Patient and drug administration risk factorsR F Spengler, J B Arrowsmith, D J Kilarski, et al.
Pageof 1